Microbot Medical
MBOT
35 hedge funds and large institutions have $1.11M invested in Microbot Medical in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 5 closing their positions.
80% more call options, than puts
Call options by funds: $9K | Put options by funds: $5K
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
6% more funds holding
Funds holding: 33 → 35 (+2)
3.26% less ownership
Funds ownership: 10.06% → 6.8% (-3.3%)
37% less capital invested
Capital invested by funds: $1.77M → $1.11M (-$661K)
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TFS
Thoroughbred Financial Services
Brentwood,
Tennessee
|
+$53.7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$28.3K |
| 3 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
+$15.9K |
| 4 |
VF
Virtu Financial
New York
|
+$13.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$483K |
| 2 |
Renaissance Technologies
New York
|
-$53.9K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$15.7K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$12.6K |
| 5 |
KWA
Kingswood Wealth Advisors
San Diego,
California
|
-$12.3K |
MBOT Hedge Fund Activity: Q2 2024 in Review
35 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2024, worth a combined $1.11M — down 37% from $1.77M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MBOT positions and 5 closed out — a net gain of 2 holders — while 4 added to existing stakes and 9 trimmed.
The largest buyer was Thoroughbred Financial Services, opening a new position worth an estimated $53.7K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $483K sold.
- 35 institutional investors held Microbot Medical (MBOT) as of Q2 2024, up from 33 in Q1 2024.
- Funds reported $1.11M of Microbot Medical stock for Q2 2024, down 37% quarter-over-quarter.
- 7 funds opened new Microbot Medical positions in Q2 2024 and 5 closed out, a net change of +2 holders.
- The largest Microbot Medical buyer in Q2 2024 was Thoroughbred Financial Services, an estimated $53.7K added.
- The largest Microbot Medical seller in Q2 2024 was Hudson Bay Capital Management, an estimated $483K sold.
Based on aggregated 13F filings for Q2 2024.